Identification of three novel B cell epitopes targeting the bovine viral diarrhea virus NS3 protein for use in diagnostics and vaccine development
Related Experiment Video
Updated: May 16, 2025

Peptide Scanning-assisted Identification of a Monoclonal Antibody-recognized Linear B-cell Epitope
Published on: March 24, 2017
Yuanyuan Zhang1, Jing Cheng2, Wenxiao Liu2
1College of Veterinary Medicine, Northwest A&F University, Yangling, China; Institute of Animal Husbandry and Veterinary Medicine, Beijing Academy of Agriculture and Forestry Sciences, Beijing, China; Research Center for Infectious Diseases in Livestock and Poultry, Beijing Academy of Agriculture and Forestry Sciences, Beijing, China; Sino-UK Joint Laboratory for Prevention & Control of Infectious Diseases in Livestock and Poultry, Beijing, China.
Abstract:
Bovine viral diarrhea virus (BVDV) is a major pathogen in cattle herds, widely distributed across the globe and causing significant economic losses to the cattle industry. The nonstructural protein NS3 is highly conserved across BVDV subtypes. Identifying and screening epitopes on BVDV NS3 is crucial for developing sensitive, specific diagnostic tools. In this study, we obtained three monoclonal antibodies (mAbs) against the NS3 protein: 2F7, 3E8, and 4D6. Three novel linear B-cell epitope 100EYG102, 384FLDIA388, and 100EYGVK104 were identified through reactions of these mAbs with a series of continuous-truncated peptides and one of which a rare three-amino-acid B-cell epitope 100EYG102. Critical amino acid residues were further characterized through alanine (A)-scanning mutagenesis. Sequence alignment revealed that 100EYG102 and 100EYGVK104 were highly conserved allowing mAbs 2F7 and 4D6 to recognize all BVDV subtypes. In contrast, 384FLDIA388 was specifically conserved in BVDV-1 and BVDV-3 enabling 3E8 mAb to differential diagnosis BVDV-2 from other BVDV subtypes. Additionally, preliminary diagnostic assays for BVDV were established by western blotting and peptide-based blocking ELISA. Moreover, we observed that these mAbs could inhibit the replication of BVDV. These findings provide a theoretical foundation for developing of therapeutic strategies for nonstructural protein and accurate diagnostic procedures.

